Aelis Farma (FRA:69O) Marketable Securities: €0.50 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:69O Aelis Farma SA FRA:69O
27 GF Score
Price €0.99
GF Value €0.94
! 4 Warning Signs
View Full Analysis

What is Aelis Farma Marketable Securities?

Aelis Farma FRA:69O +0.41% 27 Marketable Securities is €0.50 Mil as of Dec. 2025. GuruFocus rates FRA:69O with a GF Score™ of 27/100 and a GF Value™ of €0.94. The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Aelis Farma's Marketable Securities for the quarter that ended in Dec. 2025 was €0.50 Mil.

Aelis Farma's annual Marketable Securities stayed the same from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€0.00 Mil) but then increased from Dec. 2024 (€0.00 Mil) to Dec. 2025 (€0.50 Mil).

Aelis Farma  (FRA:69O) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Aelis Farma Marketable Securities Related Terms

Aelis Farma Marketable Securities Historical Data

* Premium members only.

The historical data trend for Aelis Farma's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aelis Farma Marketable Securities Chart

Aelis Farma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.50

Aelis Farma Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.50
FRA:69O
27GF Score
Aelis Farma SA FRA:69O
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aelis Farma Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €0.50 Mil mean?
Aelis Farma (FRA:69O) has a Marketable Securities of €0.50 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Aelis Farma and its competitors.
Is Aelis Farma's Marketable Securities too high?
Aelis Farma's current Marketable Securities is €0.50 Mil. Overall, Aelis Farma has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Aelis Farma's Marketable Securities compare to VRTX and REGN?
Aelis Farma's Marketable Securities of €0.50 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Aelis Farma and its competitors. Aelis Farma's current Marketable Securities is €0.50 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aelis Farma stock overvalued right now?
Aelis Farma (FRA:69O) has a current Marketable Securities of €0.50 Mil. The stock's GF Value™ is €0.94, compared to a current price of €0.99 — trading 5.1% above its estimated fair value. The current Marketable Securities is €0.50 Mil. Aelis Farma's overall GF Score™ is 27/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Aelis Farma (FRA:69O), the current Marketable Securities is €0.50 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aelis Farma (FRA:69O) Overvalued in 2026?

Based on GuruFocus' analysis, Aelis Farma stock appears to be overvalued. The current stock price of €0.99 is trading 5.1% above its estimated GF Value™ of €0.94.

Key valuation signals for FRA:69O:

  • Marketable Securities: €0.50 Mil
  • GF Value™: €0.94 vs. price of €0.99 (5.1% above fair value)
  • GF Score™: 27/100 with 4 warning signs

No single metric tells the full story. See the FRA:69O stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aelis Farma Business Description

Other Exchanges AELIS:France
Address 2 rue Robert Escarpit, IECB, Pessac, Bordeaux, FRA, 33607
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases. The Company operates in only one business segment: the research and development of pharmaceutical products.
27GF Score

Get the complete analysis for FRA:69O

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.99
Price
€0.94
GF Value